Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Non-Insulin Therapies for Diabetes Market Report for Period 2017 till 2023

Single User: $0
Multiple User: $0
Enterprise User: $0


Report Summary:

In this report, the global Non-Insulin Therapies for Diabetes market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (), revenue (Million USD), market share and growth rate of Non-Insulin Therapies for Diabetes for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Non-Insulin Therapies for Diabetes market competition by top manufacturers/players, with Non-Insulin Therapies for Diabetes sales volume, Price (), revenue (Million USD) and market share for each manufacturer/player; the top players including
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine
On the basis of product, this report displays the sales volume (), revenue (Million USD), product price (), market share and growth rate of each type, primarily split into
Alpha-glucosidase Inhibitors
Amylin Agonists
Biguanides
Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Glinides / Meglitinides
GLP-1 Analogs / GLP-1 Agonists
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
Sulfonylureas
Thiazolidinediones
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Non-Insulin Therapies for Diabetes for each application, including
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents

Global Non-Insulin Therapies for Diabetes Sales Market Report 2017
1 Non-Insulin Therapies for Diabetes Market Overview
1.1 Product Overview and Scope of Non-Insulin Therapies for Diabetes
1.2 Classification of Non-Insulin Therapies for Diabetes by Product Category
1.2.1 Global Non-Insulin Therapies for Diabetes Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Non-Insulin Therapies for Diabetes Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Alpha-glucosidase Inhibitors
1.2.4 Amylin Agonists
1.2.5 Biguanides
1.2.6 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
1.2.7 Glinides / Meglitinides
1.2.8 GLP-1 Analogs / GLP-1 Agonists
1.2.9 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
1.2.10 Sulfonylureas
1.2.11 Thiazolidinediones
1.2.12 Others
1.3 Global Non-Insulin Therapies for Diabetes Market by Application/End Users
1.3.1 Global Non-Insulin Therapies for Diabetes Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Non-Insulin Therapies for Diabetes Market by Region
1.4.1 Global Non-Insulin Therapies for Diabetes Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Non-Insulin Therapies for Diabetes Status and Prospect (2012-2022)
1.4.3 China Non-Insulin Therapies for Diabetes Status and Prospect (2012-2022)
1.4.4 Europe Non-Insulin Therapies for Diabetes Status and Prospect (2012-2022)
1.4.5 Japan Non-Insulin Therapies for Diabetes Status and Prospect (2012-2022)
1.4.6 Southeast Asia Non-Insulin Therapies for Diabetes Status and Prospect (2012-2022)
1.4.7 India Non-Insulin Therapies for Diabetes Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Non-Insulin Therapies for Diabetes (2012-2022)
1.5.1 Global Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2022)
1.5.2 Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

2 Global Non-Insulin Therapies for Diabetes Competition by Players/Suppliers, Type and Application
2.1 Global Non-Insulin Therapies for Diabetes Market Competition by Players/Suppliers
2.1.1 Global Non-Insulin Therapies for Diabetes Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Non-Insulin Therapies for Diabetes Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Non-Insulin Therapies for Diabetes (Volume and Value) by Type
2.2.1 Global Non-Insulin Therapies for Diabetes Sales and Market Share by Type (2012-2017)
2.2.2 Global Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)
2.3 Global Non-Insulin Therapies for Diabetes (Volume and Value) by Region
2.3.1 Global Non-Insulin Therapies for Diabetes Sales and Market Share by Region (2012-2017)
2.3.2 Global Non-Insulin Therapies for Diabetes Revenue and Market Share by Region (2012-2017)
2.4 Global Non-Insulin Therapies for Diabetes (Volume) by Application

3 United States Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
3.1 United States Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
3.1.1 United States Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
3.1.2 United States Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
3.1.3 United States Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
3.2 United States Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Players
3.3 United States Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Type
3.4 United States Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Application

4 China Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
4.1 China Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
4.1.1 China Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
4.1.2 China Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
4.1.3 China Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
4.2 China Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Players
4.3 China Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Type
4.4 China Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Application

5 Europe Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
5.1 Europe Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
5.1.1 Europe Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
5.1.2 Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
5.1.3 Europe Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
5.2 Europe Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Players
5.3 Europe Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Type
5.4 Europe Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Application

6 Japan Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
6.1 Japan Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
6.1.1 Japan Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
6.1.2 Japan Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
6.1.3 Japan Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
6.2 Japan Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Players
6.3 Japan Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Type
6.4 Japan Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Application

7 Southeast Asia Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
7.1 Southeast Asia Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
7.1.1 Southeast Asia Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
7.2 Southeast Asia Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Players
7.3 Southeast Asia Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Type
7.4 Southeast Asia Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Application

8 India Non-Insulin Therapies for Diabetes (Volume, Value and Sales Price)
8.1 India Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
8.1.1 India Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
8.1.2 India Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
8.1.3 India Non-Insulin Therapies for Diabetes Sales Price Trend (2012-2017)
8.2 India Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Players
8.3 India Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Type
8.4 India Non-Insulin Therapies for Diabetes Sales Volume and Market Share by Application

9 Global Non-Insulin Therapies for Diabetes Players/Suppliers Profiles and Sales Data
9.1 GSK
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 GSK Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Eli Lilly
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Sumitomo Dainippon Pharma
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Intarcia Therapeutics
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Servier
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Servier Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Jiangsu Hansoh Pharmaceutical
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Novo Nordisk Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Emisphere
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Emisphere Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Uni-Bio Science Group
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Takeda
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Non-Insulin Therapies for Diabetes Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Takeda Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 3SBio
9.12 Merck
9.13 Dong-A Pharmaceutical
9.14 Luye Pharma Group
9.15 Eurofarma
9.16 Geropharm
9.17 Alkem Labs
9.18 SatRx
9.19 Pfizer
9.20 Jiangsu Hengrui Medicine

10 Non-Insulin Therapies for Diabetes Maufacturing Cost Analysis
10.1 Non-Insulin Therapies for Diabetes Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
10.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Non-Insulin Therapies for Diabetes Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Non-Insulin Therapies for Diabetes Market Forecast (2017-2022)
14.1 Global Non-Insulin Therapies for Diabetes Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Non-Insulin Therapies for Diabetes Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Non-Insulin Therapies for Diabetes Price and Trend Forecast (2017-2022)
14.2 Global Non-Insulin Therapies for Diabetes Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Non-Insulin Therapies for Diabetes Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Non-Insulin Therapies for Diabetes Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Non-Insulin Therapies for Diabetes Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Non-Insulin Therapies for Diabetes Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Non-Insulin Therapies for Diabetes Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Non-Insulin Therapies for Diabetes Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Non-Insulin Therapies for Diabetes Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Non-Insulin Therapies for Diabetes Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Non-Insulin Therapies for Diabetes Sales Forecast by Type (2017-2022)
14.3.2 Global Non-Insulin Therapies for Diabetes Revenue Forecast by Type (2017-2022)
14.3.3 Global Non-Insulin Therapies for Diabetes Price Forecast by Type (2017-2022)
14.4 Global Non-Insulin Therapies for Diabetes Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 24 hours.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 37977

Category: 16

Published date: 2017-12-03 20:12:16

Number of Pages: 110

Publisher Name:

Over all Rating: 0 % (Average of Ratings provided by clients)